325 related articles for article (PubMed ID: 8195712)
21. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.
Sevinsky JR; Rao LV; Ruf W
J Cell Biol; 1996 Apr; 133(2):293-304. PubMed ID: 8609163
[TBL] [Abstract][Full Text] [Related]
22. Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription-polymerase chain reaction.
Iochmann S; Reverdiau-Moalic P; Beaujean S; Rideau E; Lebranchu Y; Bardos P; Gruel Y
Thromb Res; 1999 May; 94(3):165-73. PubMed ID: 10326763
[TBL] [Abstract][Full Text] [Related]
23. Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor.
Puy C; Tucker EI; Matafonov A; Cheng Q; Zientek KD; Gailani D; Gruber A; McCarty OJ
Blood; 2015 Feb; 125(9):1488-96. PubMed ID: 25587039
[TBL] [Abstract][Full Text] [Related]
24. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction.
Steppich B; Mattisek C; Sobczyk D; Kastrati A; Schömig A; Ott I
Thromb Haemost; 2005 Jan; 93(1):35-9. PubMed ID: 15630488
[TBL] [Abstract][Full Text] [Related]
25. Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.
Santamaria S; Reglińska-Matveyev N; Gierula M; Camire RM; Crawley JTB; Lane DA; Ahnström J
J Biol Chem; 2017 Jun; 292(22):9335-9344. PubMed ID: 28420729
[TBL] [Abstract][Full Text] [Related]
26. Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation.
Okugawa Y; Wada H; Noda T; Sakakura M; Nakasaki T; Watanabe R; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Deguchi K; Nobori T; Shiku H
Am J Hematol; 2000 Nov; 65(3):210-4. PubMed ID: 11074537
[TBL] [Abstract][Full Text] [Related]
27. Role of the tissue factor pathway in synovial inflammation.
Busso N; Morard C; Salvi R; Péclat V; So A
Arthritis Rheum; 2003 Mar; 48(3):651-9. PubMed ID: 12632417
[TBL] [Abstract][Full Text] [Related]
28. The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes.
Basavaraj MG; Gruber FX; Sovershaev M; Appelbom HI; Osterud B; Petersen LC; Hansen JB
Thromb Res; 2010 Nov; 126(5):418-25. PubMed ID: 20723970
[TBL] [Abstract][Full Text] [Related]
29. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.
Hackeng TM; Seré KM; Tans G; Rosing J
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3106-11. PubMed ID: 16488980
[TBL] [Abstract][Full Text] [Related]
30. Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI.
Henriquez S; Calderon C; Quezada M; Oliva B; Bravo ML; Aranda E; Kato S; Cuello MA; Gutiérrez J; Quest AF; Owen GI
J Cell Physiol; 2011 Dec; 226(12):3278-85. PubMed ID: 21344386
[TBL] [Abstract][Full Text] [Related]
31. EPAS1/HIF-2 alpha-mediated downregulation of tissue factor pathway inhibitor leads to a pro-thrombotic potential in endothelial cells.
Stavik B; Espada S; Cui XY; Iversen N; Holm S; Mowinkel MC; Halvorsen B; Skretting G; Sandset PM
Biochim Biophys Acta; 2016 Apr; 1862(4):670-678. PubMed ID: 26826018
[TBL] [Abstract][Full Text] [Related]
32. Initiation of the extrinsic pathway of coagulation by human and rabbit alveolar macrophages: a kinetic study.
McGee MP; Wallin R; Wheeler FB; Rothberger H
Blood; 1989 Oct; 74(5):1583-90. PubMed ID: 2790188
[TBL] [Abstract][Full Text] [Related]
33. Protein S is a cofactor for tissue factor pathway inhibitor.
Rosing J; Maurissen LF; Tchaikovski SN; Tans G; Hackeng TM
Thromb Res; 2008; 122 Suppl 1():S60-3. PubMed ID: 18691502
[TBL] [Abstract][Full Text] [Related]
34. Suppression of human monocyte tissue factor synthesis by antisense oligodeoxynucleotide.
Stephens AC; Rivers RP
Thromb Res; 1997 Mar; 85(5):387-98. PubMed ID: 9076896
[TBL] [Abstract][Full Text] [Related]
35. The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor.
Bastarache JA; Wang L; Geiser T; Wang Z; Albertine KH; Matthay MA; Ware LB
Thorax; 2007 Jul; 62(7):608-16. PubMed ID: 17356058
[TBL] [Abstract][Full Text] [Related]
36. Circulating monocytes mirror the imbalance in TF and TFPI expression in carotid atherosclerotic plaques with lipid-rich and calcified morphology.
Basavaraj MG; Sovershaev MA; Egorina EM; Gruber FX; Bogdanov VY; Fallon JT; Østerud B; Mathiesen EB; Hansen JB
Thromb Res; 2012 Apr; 129(4):e134-41. PubMed ID: 22178066
[TBL] [Abstract][Full Text] [Related]
37. Expression of tissue factor and tissue factor pathway inhibitor in rats lungs with lipopolysaccharide-induced disseminated intravascular coagulation.
Hara S; Asada Y; Hatakeyama K; Marutsuka K; Sato Y; Kisanuki A; Sumiyoshi A
Lab Invest; 1997 Dec; 77(6):581-9. PubMed ID: 9426395
[TBL] [Abstract][Full Text] [Related]
38. C-reactive protein does not directly induce tissue factor in human monocytes.
Paffen E; Vos HL; Bertina RM
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):975-81. PubMed ID: 15044210
[TBL] [Abstract][Full Text] [Related]
39. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
Audu P; Nielsen VG; Armstead V; Powell G; Kim J; Kim L; Mehta M
Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity.
Kopp CW; Hölzenbein T; Steiner S; Marculescu R; Bergmeister H; Seidinger D; Mosberger I; Kaun C; Cejna M; Horvat R; Wojta J; Maurer G; Binder BR; Breuss JM; Ecker RC; de Martin R; Minar E
Blood; 2004 Mar; 103(5):1653-61. PubMed ID: 14592830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
